Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Duarte › NPI 1871886366
Physician

City of Hope Medical Foundation

City of Hope Medical Foundation was paid $40.53M by Medicaid between Jan 2018 and Dec 2024, across 185 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.

33Billing provider infoCITY OF HOPE MEDICAL FOUNDATION
DUARTE, CA 91010
33aNPI1871886366assigned 05/17/2011
33bProvider typeAnesthesiology Physician
28Total paid$40.53M
24GClaims728,218
24DCodes billed185
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Anesthesiology Physician providers in California

Rank by total paid#2 of 415
Median peer was paid$17K
This provider vs. median2,319×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201874,245$3.34M
201981,536$4.50M
202090,785$4.62M
2021102,066$5.65M
2022106,116$5.88M
2023136,074$8.68M
2024incomplete137,396$7.85M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 13% 126,958 109,269 $5.44M
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 11% 26,774 3,416 $4.65M
J9271 Injection, pembrolizumab, 1 mg 7.4% 637 518 $3.01M
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 5.5% 41,609 32,375 $2.23M
77014 4.7% 46,303 6,722 $1.92M
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m 4.7% 42,567 9,933 $1.91M
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity 4.0% 48,519 13,162 $1.64M
J0897 Injection, denosumab, 1 mg 3.3% 1,738 1,697 $1.34M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3.1% 49,041 46,478 $1.27M
78815 Positron emission tomography (PET) for limited area imaging 3.1% 6,495 6,377 $1.25M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.4% 16,827 10,985 $956K
77427 1.8% 10,179 4,892 $746K
173 more codes
77301 1.8% 1,317 $724K
99223 Prolong inpt eval add15 m 1.7% 8,071 $677K
88305 Level IV - Surgical pathology, gross and microscopic examination 1.6% 15,739 $665K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 1.5% 473 $599K
G6012 Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev 1.3% 4,430 $528K
J2505 Injection, pegfilgrastim, 6 mg 1.2% 218 $476K
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 1.1% 64 $427K
77334 1.0% 4,602 $411K
74178 1.0% 8,030 $407K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 6,353 $405K
99205 Prolong outpt/office vis <1% 5,845 $378K
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg <1% 384 $355K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14,382 $347K
77338 <1% 2,113 $347K
96375 Therapeutic injection; each additional sequential IV push <1% 11,046 $343K
J0185 Injection, aprepitant, 1 mg <1% 1,849 $336K
99204 Doctor's office visit, new patient (more involved) <1% 5,773 $328K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,211 $274K
88342 <1% 8,319 $271K
77263 <1% 2,868 $263K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 5,613 $239K
77300 <1% 3,184 $234K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 679 $232K
J9299 Injection, nivolumab, 1 mg <1% 84 $227K
77336 <1% 6,542 $226K
99222 Initial hospital care, per day, moderate complexity <1% 3,746 $195K
88341 <1% 4,347 $173K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 266 $158K
G0452 Molecular pathology procedure; physician interpretation and report <1% 7,146 $157K
G6002 Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy <1% 4,988 $156K
77295 <1% 669 $149K
88189 <1% 2,397 $140K
88108 <1% 7,883 $134K
88321 <1% 3,354 $134K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 18,078 $129K
76641 <1% 5,144 $121K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 53 $116K
77290 <1% 1,422 $110K
85097 <1% 3,195 $100K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,600 $100K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,244 $99K
88307 <1% 1,262 $98K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 2,146 $96K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 5,532 $95K
J9035 Injection, bevacizumab, 10 mg <1% 76 $94K
96417 <1% 3,396 $91K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,901 $85K
88360 <1% 1,461 $78K
96367 <1% 2,275 $68K
99442 <1% 2,089 $68K
G6017 Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment <1% 126 $63K
96450 <1% 541 $63K
36522 <1% 111 $57K
71045 Radiologic examination, chest; single view <1% 10,584 $56K
99152 <1% 2,870 $49K
77470 <1% 697 $47K
99221 <1% 1,385 $44K
38222 <1% 657 $43K
96415 <1% 2,095 $43K
71250 <1% 2,032 $40K
99203 Doctor's office visit, new patient (routine) <1% 1,292 $39K
77280 <1% 1,001 $38K
85060 <1% 2,627 $35K
74183 <1% 756 $34K
99443 <1% 1,016 $34K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 137 $31K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,132 $30K
52000 <1% 804 $30K
71046 Radiologic examination, chest; 2 views <1% 4,832 $30K
96401 <1% 198 $29K
88381 <1% 582 $28K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 1,761 $27K
93356 <1% 1,280 $25K
99255 <1% 238 $22K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,359 $21K
77065 Tomosynthesis, mammo <1% 1,032 $21K
96402 <1% 747 $18K
99497 <1% 392 $18K
88311 <1% 2,936 $17K
77066 Tomosynthesis, mammo <1% 710 $17K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 1,600 $17K
99239 Hospital discharge day management, more than 30 minutes <1% 391 $16K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 155 $16K
84165 <1% 5,598 $15K
94727 <1% 1,655 $15K
93307 <1% 536 $15K
99441 <1% 692 $14K
J9395 Injection, fulvestrant, 25 mg <1% 154 $14K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,347 $13K
99417 Prolong home eval add 15m <1% 213 $13K
J0640 Injection, leucovorin calcium, per 50 mg <1% 509 $13K
94729 <1% 2,047 $12K
J9202 Goserelin acetate implant, per 3.6 mg <1% 27 $12K
96361 Intravenous infusion, hydration; each additional hour <1% 1,671 $11K
94010 <1% 1,307 $10K
72197 <1% 233 $10K
J9267 Injection, paclitaxel, 1 mg <1% 466 $10K
78816 <1% 65 $10K
51798 <1% 638 $10K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 145 $10K
77003 <1% 577 $10K
96377 <1% 374 $9K
96411 <1% 357 $9K
86334 <1% 2,096 $9K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,173 $8K
88188 <1% 143 $8K
78306 <1% 435 $7K
77049 <1% 97 $7K
70491 <1% 256 $7K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion <1% 116 $7K
96523 <1% 450 $7K
76937 <1% 719 $6K
J1453 Injection, fosaprepitant, 1 mg <1% 32 $6K
51701 <1% 191 $6K
88333 <1% 132 $6K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 502 $5K
88312 <1% 245 $5K
77001 <1% 510 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,020 $5K
70450 Computed tomography, head or brain; without contrast material <1% 226 $4K
J9190 Injection, fluorouracil, 500 mg <1% 824 $4K
88313 <1% 132 $4K
36561 <1% 25 $4K
96368 <1% 276 $4K
76536 <1% 304 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 124 $3K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 31 $3K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 899 $3K
J9045 Injection, carboplatin, 50 mg <1% 222 $3K
77080 <1% 448 $3K
77067 Screening mammography, bilateral, including computer-aided detection <1% 62 $3K
36591 <1% 283 $2K
88173 <1% 51 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 129 $2K
31575 <1% 39 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 107 $2K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units <1% 40 $2K
00731 <1% 55 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 108 $1K
94060 <1% 127 $1K
J3490 Unclassified drugs <1% 2,113 $1K
93970 <1% 79 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 843 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 62 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 4,590 $1K
76830 Ultrasound, transvaginal <1% 67 $1K
76942 <1% 92 $1K
99386 <1% 19 $1K
72158 <1% 18 $841.67
J9263 Injection, oxaliplatin, 0.5 mg <1% 54 $820.95
J7030 Infusion, normal saline solution , 1000 cc <1% 866 $759.54
94726 <1% 86 $738.56
76642 <1% 17 $711.78
99238 Hospital discharge day management, 30 minutes or less <1% 28 $656.28
88309 <1% 12 $622.64
51702 <1% 13 $579.88
36620 <1% 24 $531.22
71020 <1% 65 $529.50
01992 <1% 12 $514.83
J3489 Injection, zoledronic acid, 1 mg <1% 14 $484.88
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 27 $463.82
00811 <1% 20 $412.53
77417 <1% 29 $364.79
95251 <1% 12 $312.03
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) <1% 27 $296.16
74018 <1% 49 $285.63
74420 <1% 29 $280.10
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 33 $219.52
71010 <1% 27 $172.94
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 29 $153.41
93971 <1% 13 $145.03
86320 <1% 15 $110.09
88300 <1% 12 $11.89

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJENSEN, VINCE (CHIEF EXECUTIVE)